Andreas Lügering

3.6k total citations
58 papers, 2.6k citations indexed

About

Andreas Lügering is a scholar working on Immunology, Epidemiology and Genetics. According to data from OpenAlex, Andreas Lügering has authored 58 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Immunology, 22 papers in Epidemiology and 22 papers in Genetics. Recurrent topics in Andreas Lügering's work include Inflammatory Bowel Disease (19 papers), Microscopic Colitis (14 papers) and Immune Response and Inflammation (10 papers). Andreas Lügering is often cited by papers focused on Inflammatory Bowel Disease (19 papers), Microscopic Colitis (14 papers) and Immune Response and Inflammation (10 papers). Andreas Lügering collaborates with scholars based in Germany, United States and Croatia. Andreas Lügering's co-authors include Torsten Kucharzik, Norbert Lügering, W Domschke, Michael Schmidt, Hans‐Gerd Pauels, Wolfram Domschke, Jan Heidemann, Christian Maaser, Klaus Schulze‐Osthoff and Christopher Poremba and has published in prestigious journals such as The Journal of Immunology, Gastroenterology and Hepatology.

In The Last Decade

Andreas Lügering

56 papers receiving 2.5k citations

Peers

Countries citing papers authored by Andreas Lügering

Since Specialization

Citations

This map shows the geographic impact of Andreas Lügering's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andreas Lügering with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andreas Lügering more than expected).

Fields of papers citing papers by Andreas Lügering

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andreas Lügering. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andreas Lügering. The network helps show where Andreas Lügering may publish in the future.

Co-authorship network of co-authors of Andreas Lügering

This figure shows the co-authorship network connecting the top 25 collaborators of Andreas Lügering. A scholar is included among the top collaborators of Andreas Lügering based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andreas Lügering. Andreas Lügering is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Real-world effectiveness of ustekinumab versus anti-TNF or vedolizumab in ulcerative colitis: induction and 12-month maintenance results from the prospective, observational RUN-UC study 2025 ·Journal of Crohn s and Colitis ·Bernd Bokemeyer, Sandra Plachta‐Danielzik, (unknown), Stefanie Howaldt, Wolfgang Mohl, (unknown), Robert Ehehalt, (unknown), Thomas Krause, (unknown), Andreas Lügering, Elisabeth Schnoy, Christoph Jochum, Petra Hartmann, Stefan Schreiber	1
2	Tu1705 DELAYED CLINICAL RESPONSE IN PATIENTS WITH CROHN'S DISEASE RECEIVING UPADACITINIB THERAPY 2023 ·Gastroenterology ·Geert D’Haens, Jakob Benedict Seidelin, Andreas Lügering, Esther A. Torres, Mark R. Fleisher, Gerald W. Dryden, Ana P. Lacerda, Elena Dubcenco, (unknown), Daniel J. O’Brien, Feng Tian, Jianzhong Liu, Pascal Juillerat	2
3	Self-assessment of treatment targets in patients with inflammatory bowel disease using a survey 2020 ·Therapeutic Advances in Gastroenterology ·Philipp A. Reuken, Philip Grunert, Andreas Lügering, Niels Teich, Andreas Stallmach	3
4	Predictive parameters for the clinical course of Crohn’s disease: development of a simple and reliable risk model 2019 ·International Journal of Colorectal Disease ·(unknown), Andreas Stallmach, Bernd Bokemeyer, Ulf Helwig, Andreas Lügering, Niels Teich, Imma Fischer, Stefan Rath, (unknown), Carsten Schmidt	8
5	Translational ¹⁸F-FDG PET/CT Imaging to Monitor Lesion Activity in Intestinal Inflammation 2013 ·Journal of Nuclear Medicine ·Dominik Bettenworth, Stefan Reuter, Sven Hermann, Matthias Weckesser, (unknown), Athanasios Stratis, Tobias M. Nowacki, Matthias Ross, Frank Lenze, Bayram Edemir, Christian Maaser, Thomas Pap, Steffen Koschmieder, Jan Heidemann, Michael Schäfers, Andreas Lügering	49
6	Improving Relapse Prediction in Inflammatory Bowel Disease by Neutrophil-Derived S100A12 2013 ·Inflammatory Bowel Diseases ·Jan Däbritz, Jost Langhorst, Andreas Lügering, Jan Heidemann, (unknown), Helmut Wittkowski, Thomas Krummenerl, Dirk Foell	61
7	Glucocorticoid-Stimulated Monocytes (GCsM) Control T Cell-Induced Colitis in Vivo 2012 ·(unknown), (unknown), Jan Ehrchen, Nadine Nippe, Athanasios Tsianakas, Matthias Ross, Andreas Lügering, Johannes Roth, (unknown)	1
8	Green tea polyphenol epigallocatechin-3-gallate shows therapeutic antioxidative effects in a murine model of colitis 2011 ·Journal of Crohn s and Colitis ·Markus Brückner, Sabine Westphal, Wolfram Domschke, Torsten Kucharzik, Andreas Lügering	116
9	Long-term efficacy and safety of double balloon enteroscopy – prospective and retrospective data from a single center study 2010 ·Scandinavian Journal of Gastroenterology ·Christian Maaser, (unknown), (unknown), Klaus Kannengießer, H Ullerich, Andreas Lügering, Dirk Domagk, Wolfram Domschke, Torsten Kucharzik	15
10	Terminal Signal: Anti-Inflammatory Effects of α-Melanocyte-Stimulating Hormone Related Peptides Beyond the Pharmacophore 2010 ·Advances in experimental medicine and biology ·Thomas Brzoska, Markus Böhm, Andreas Lügering, Karin Loser, Thomas A. Luger	30
11	Gastric Epithelial Expression of Macrophage Migration Inhibitory Factor is not Altered by Helicobacter pylori Infection in Humans 2006 ·Helicobacter ·Pia Lebiedz, Jan Heidemann, Andreas Lügering, (unknown), Hermann Herbst, Wolfram Domschke, Torsten Kucharzik, Christian Maaser	4
12	Induction of Intestinal Lymphoid Tissue 2006 ·Annals of the New York Academy of Sciences ·Andreas Lügering, Torsten Kucharzik	10
13	Intestinal Cryptopatch Formation in Mice Requires Lymphotoxin α and the Lymphotoxin β Receptor 2004 ·The Journal of Immunology ·Rebekah T. Taylor, Andreas Lügering, Kenneth A. Newell, Ifor R. Williams	46
14	The lymphotoxin-β receptor is critical for control of murine Citrobacter rodentium–induced colitis 2004 ·Gastroenterology ·Thomas W. Spahn, Christian Maaser, Lars Eckmann, Jan Heidemann, Andreas Lügering, Rodney D. Newberry, Wolfram Domschke, Hermann Herbst, Torsten Kucharzik	52
15	Detection of apoptotic caspase activation in sera from patients with chronic HCV infection is associated with fibrotic liver injury 2004 ·Hepatology ·Heike Bantel, Andreas Lügering, Jan Heidemann, X Volkmann, Christopher Poremba, Christian P. Strassburg, Michael P. Manns, Klaus Schulze‐Osthoff	198
16	Lymphoid Precursors in Intestinal Cryptopatches Express CCR6 and Undergo Dysregulated Development in the Absence of CCR6 2003 ·The Journal of Immunology ·Andreas Lügering, Torsten Kucharzik, Dulce Soler, Dominic Picarella, (unknown), Ifor R. Williams	35
17	Role of the CD95/CD95 Ligand System in Glucocorticoid-Induced Monocyte Apoptosis 2001 ·The Journal of Immunology ·Michael Schmidt, Norbert Lügering, Andreas Lügering, Hans‐Gerd Pauels, Klaus Schulze‐Osthoff, W Domschke, Torsten Kucharzik	56
18	Caspase activation correlates with the degree of inflammatory liver injury in chronic hepatitis C virus infection 2001 ·Hepatology ·Heike Bantel, Andreas Lügering, Christopher Poremba, Norbert Lügering, Jürgen Held, Wolfram Domschke, Klaus Schulze‐Osthoff	143
19	Glucocorticoids Induce Apoptosis in Human Monocytes: Potential Role of IL-1β 1999 ·The Journal of Immunology ·Michael Schmidt, Hans‐Gerd Pauels, Norbert Lügering, Andreas Lügering, W Domschke, Torsten Kucharzik	93
20	IL-10 Synergizes with IL-4 and IL-13 in Inhibiting Lysosomal Enzyme Secretion by Human Monocytes and Lamina Propria Mononuclear Cells from Patients with Inflammatory Bowel Disease 1998 ·Digestive Diseases and Sciences ·Norbert Lügering, Torsten Kucharzik, Henning Stein, G Winde, Andreas Lügering, Andrej Hasilík, W Domschke, (unknown)	38

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact